- GLP1RA medications linked to behavioral side effects in type 2 diabetes and obesity News-Medical.Net
- The Ozempic debate: Large study reveals the good and the bad Global News Toronto
- Mapping the effectiveness and risks of GLP-1 receptor agonists Nature.com
- Ozempic could also help fight dementia but raise other health risks, study says CBC News
- GLP-1 drugs like Ozempic and Wegovy lower the risk of 42 conditions New Scientist
Add Comment